Business Context and Reporting Period
This Form 8-K Current Report was filed by India Globalization Capital, Inc. (not IGC Pharma, Inc.) on April 2, 2014. The report details the entry into a material definitive agreement regarding a private placement of common stock.
Key Financial Metrics
- Capital Raised: $506,250 in gross proceeds.
- Shares Issued: 750,000 shares of common stock.
- Placement Fee: 7% of gross proceeds paid to Midtown Partners & Co., LLC.
- Other Metrics: The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the increase in equity capital through the issuance of 750,000 shares to institutional investors. This transaction closed on April 2, 2014, subject to customary conditions.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the anticipated closing of the offering. Management directs investors to the company's Form 10-K and Form 10-Q filings for a detailed discussion of risks and uncertainties. No specific financial guidance or outlook was provided in this document.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 7% placement fee and reimbursed expenses.
- Confirm the dilution impact of the 750,000 new shares on existing shareholders.
- Review the attached Securities Purchase Agreement (Exhibit 10.1) for specific investor rights or restrictions.
- Check the company's most recent 10-K or 10-Q for current cash position and liquidity status, as this 8-K does not contain balance sheet data.